Content Status
Type
Linked Node
Role of Treatment Supporter in SCM
Learning ObjectivesRole of Treatment Supporter in SCM
H5Content
Content
Ensuring adherence to correct treatment is crucial in the outcome of tuberculosis and hence it is essential to develop a patient-centred approach to treatment administration.
- A Treatment Supporter (TS) who is acceptable and accessible to the patient as well as accountable to the health system should be identified in consultation with the patient during pre-treatment evaluation.
- The TS can either be a healthcare worker, community worker/ volunteer or private practitioner or family member.
- If a family member is identified as TS s/he should be trained to give medication under supervision at the residence, under close monitoring by Community Health Officer (CHO)/ Accredited Social Health Activist (ASHA)/ Auxilliary Nurse Midwife (ANM)/ Multipurpose Workers (MPW) with support from Tuberculosis Health Visitor (TBHV)/ Senior Treatment Supervisor (STS).
Role of TS in Supply Chain Management
- Whenever a patient is initiated on treatment, the monthly patient-wise boxes are issued to the TS of the patient.
- In the case of Bedaquiline (Bdq) since the treatment is initiated at the Nodal/ District DR-TB Centre (N/DDR-TBC), on discharge, the patient is issued the remaining bottle of Bdq drug, which is then handed over to the TS.
- In the case of Delamanid (Dlm), on discharge from the N/DDR TBC the remaining drugs for the rest of the first month are issued to the patient which is then handed over to the TS.
- In any case, TS is responsible for issuing the medicines to the patient on a daily basis until the end of the course, thereby ensuring Direct Observation of Treatment (DOT).
- The TS are also responsible for collecting/ receiving month-wise boxes throughout the treatment duration of the patient.
- The TS is assigned to the Ni-kshay database with respect to the particular patient and issued a Treatment Card to maintain a record of all drugs consumed by the patient.
- In case of death/ loss to follow-up/ discontinuation of treatment due to any reason or in case of change/ modification of the regimen, the TS is responsible for returning the issued patient wise box back to the treatment centre and also ensuring that the new/modified regimen box is issued to the patient.
Resources
- Standard Operating Procedure Manual Procurement & Supply Chain Management, CTD, MoHFW, India, 2018.
- Procurement, Supply Chain Management & Preventive Maintenance, Module 6, CTD, MoHFW, India.
- Direct Benefit Transfer Manual for National Tuberculosis Elimination Programme, Central TB Division, Ministry of Health & Family Welfare, India, 2021.
Assessment
Question | Answer 1 | Answer 2 | Answer 3 | Answer 4 | Correct answer | Correct explanation | Page id | Part of Pre-test | Part of Post-test |
In the case of Delamanid (Dlm), on discharge from the N/DDR TBC the remaining drugs for the rest of the first month are issued to the patient, which is then handed over to the TS. | True | False | 1 | In the case of Delamanid (Dlm), on discharge from the N/DDR TBC the remaining drugs for the rest of the first month are issued to the patient which is then handed over to the TS. | | Yes | Yes |
LMS Page Link
Content Creator
Reviewer
Target Audience
- Log in to post comments